"10.1371_journal.pone.0073625","plos one","2013-09-16T00:00:00Z","Naama Dror; Mathilda Mandel; Gad Lavie","Department of Cellular and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; The Blood Center, Sheba Medical Center, Tel-Hashomer, Israel","Conceived and designed the experiments: ND GL MM. Performed the experiments: ND. Analyzed the data: GL ND MM. Contributed reagents/materials/analysis tools: GL. Wrote the paper: GL MM. Proposed directions in project: MM. Directed the project: GL.","Gad Lavie has fiancial interest in Hy Biopjarma Ltd., a company that develops hypericin as an anti-cancer drug. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Naama Dror","ND",3,TRUE,3,1,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
